SEC Form 4 · accession 0001209191-17-002922
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick Leschly
Officer — President and CEO · Director
Period of report
Jan 5, 2017
Accepted (ET)
Jan 9, 2017 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2016 | G | 7,500 | $0.00 | D | 348,370 | D | |
| Common StockF1,F2 | Jan 5, 2017 | S | 2,024 | $67.10 | D | 346,346 | D | |
| Common Stock | holding | — | — | — | 17,186 | I | Nick Leschly 2001 Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- F2The range in prices for the transaction reported on this line was $67.00 to $67.50. The average weighted price was $67.10. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.